FOSL1 and breast carcinoma: In lung and breast cancer cells, PARP7 loss-of-function reduces cell proliferation and survival through downregulation of the transcription factor FRA1 (also known as FOSL1), which inhibits the interferon regulatory factors IRF1 and IRF3.